ARID1A and colorectal cancer: AP-1 has the potential to be pro- or anti-tumorigenic depending on context [19] and at least in ARID1A-null colorectal cancer cells, changes in genome regulation implicate AP-1 in controlling new gene networks associated with the regulation of oncogenic gene expression [15].